Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...51525354555657585960...
CompanyDrug NameStatusIndication Group
AETERNA ZENTARIS Cetrotide Approved in JapanGenito urinary system & sex hormones
BioAxone Therapeutics Cethrin in Phase IINervous system
Novartis Certican Approved in USA and EUAntineoplastic & immunomodulating agents
AstraZeneca Cerovive discontinuedCardiovascular system
Neurochem Cerebril accomplished Phase IICardiovascular system
Roche CERA Submitted for approval in USABlood & blood forming organs
Roche CERA Submitted for approval in USA and EUBlood & blood forming organs
Baxter International CEPROTIN Approved in USAAlimentary tract & metabolism
EpiCept Ceplene and IL-2 discontinuedAntineoplastic & immunomodulating agents
EpiCept Ceplene and IL-2 Submitted for approval in EUAntineoplastic & immunomodulating agents
EpiCept Ceplene in Phase IIAnti-infectives for systemic use
EpiCept Ceplene Submitted for approval in EUAntineoplastic & immunomodulating agents
Barr Laboratories Cenestin Approved in USACardiovascular system
Aspreva CellCept accomplished Phase IIIAntineoplastic & immunomodulating agents
Aspreva CellCept in Phase IIIAntineoplastic & immunomodulating agents
Chiron cell culture-derived influenza vaccine in Phase IIAntineoplastic & immunomodulating agents
Vasogen Celacade accomplished Phase IICardiovascular system
Vasogen Celacade accomplished Phase IIICardiovascular system
Baxter International Ceftriaxone Injection Approved in USAAnti-infectives for systemic use
ChemGenex Ceflatonin in Phase IIIAntineoplastic & immunomodulating agents
...51525354555657585960...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.